Clinical Trial Update: Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial comparing nebivolol and timolol suspensions to timolol solution for open-angle glaucoma and ocular hypertension; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Nebivolol 0.5 suspension (nebivolol)
• Nebivolol 1.0 suspension (nebivolol)
• Timolol 0.5 solution (timolol)
• Timolol 0.5 suspension (timolol)

Snippet

Sponsor: Betaliq, Inc. | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2024-04-17